Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Sinovac Biotech
(NASDAQ:SVA)
Intraday
$5.85
After-Hours
$5.85
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$5.85
At close: Dec 24
$5.85
0
[0.00%]
PreMarket: 9:29AM EDT
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Sinovac Biotech Stock (NASDAQ:SVA)
Sinovac Biotech Stock (NASDAQ: SVA)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, September 11, 2023
SINOVAC Updates on the Clinical Trial Progress of its Anti-COVID-19 Antibody SA55 Injection
Benzinga Newsdesk
-
Sep 11, 2023, 5:58AM
Tuesday, September 05, 2023
Sinovac Biotech Board Unanimously Rejects an Unsolicited Partial Tender Offer from Alternative Liquidity Index To Acquire up to 10M Shares of Sinovac Biotech for $0.03/Share in Cash
Benzinga Newsdesk
-
Sep 5, 2023, 4:16AM
Tuesday, August 29, 2023
Alternative Liquidity Index Offers To Acquire up to 10M Shares of Sinovac Biotech for $0.03/Share in Cash
Benzinga Newsdesk
-
Aug 29, 2023, 3:17AM
Wednesday, March 29, 2023
CSPC Pharma Wins China's mRNA Vaccine Race, But Just Not Fast Enough
The Bamboo Works
-
Mar 29, 2023, 9:06AM
Wednesday, February 22, 2023
Sinovac Biotech Board Amends Shareholder Rights Plan, Extends Expiration Date From February 22, 2023 To February 22, 2024
Benzinga Newsdesk
-
Feb 22, 2023, 6:14AM
Thursday, January 05, 2023
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
Benzinga Insights
-
Jan 5, 2023, 10:01AM
Tuesday, November 22, 2022
Jim Cramer Says China's Vaccines 'Don't Work' But Xi Won't Admit It
Adam Eckert
-
Nov 22, 2022, 2:45PM
Friday, November 04, 2022
Reported Late Thursday, Sinovac Biotech's Varicella Vaccine Prequalified By WHO
Benzinga Newsdesk
-
Nov 4, 2022, 12:58AM
Tuesday, September 06, 2022
SINOVAC Approved to Initiate Clinical Trial for Its Omicron Containing COVID-19 Vaccine in Chile
Bill Haddad
-
Sep 6, 2022, 6:01AM
Wednesday, August 03, 2022
Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial
Vandana Singh
-
Aug 3, 2022, 10:13AM
SINOVAC COVID-19 Vaccine Approved For Use In Children Above 6 months Of Age in Hong Kong
Benzinga Newsdesk
-
Aug 3, 2022, 6:06AM
Friday, July 29, 2022
Shares of Chinese companies are trading lower after President Xi held an economic meeting yesterday and did not indicate an economic growth stimulus was imminent. China also reiterated the 'zero-COVID policy'
Benzinga Newsdesk
-
Jul 29, 2022, 10:57AM
Wednesday, July 13, 2022
Which COVID-19 Vaccine(s) Significantly Prevented Deaths - Read To Find Out
Vandana Singh
-
Jul 13, 2022, 7:32AM
Tuesday, July 05, 2022
Benzinga's Top Ratings Upgrades, Downgrades For July 5, 2022
Benzinga Insights
-
Jul 5, 2022, 10:04AM
Thursday, May 26, 2022
CanSino's Covid Vaccine Gets WHO Nod. But Is It Too Little, Too Late?
The Bamboo Works
-
May 26, 2022, 2:05PM
Wednesday, January 26, 2022
New Energy Lands as Hottest Category Among Chinese Concept Stocks in 2021 – Bamboo Works Special Report
The Bamboo Works
-
Jan 26, 2022, 1:13PM
Monday, January 24, 2022
Pfizer, AstraZeneca or J&J COVID-19 Shots Boost Sinovac Regime, Brazilian Study Shows
Vandana Singh
-
Jan 24, 2022, 12:44PM
Monday, January 03, 2022
Sinovac's COVID-19 Vaccine With Pfizer Booster Less Effective Against Omicron: Reuters
Vandana Singh
-
Jan 3, 2022, 7:23AM
Thursday, December 30, 2021
SINOVAC Reports Unaudited First Half 2021 Sales Results Of $11B, Up From $67.7M YoY
Benzinga Newsdesk
-
Dec 30, 2021, 4:08PM
Thursday, December 23, 2021
Three Sinovac Doses Fail to Protect Against Omicron in Study
Charles Gross
-
Dec 23, 2021, 5:12AM
Monday, December 13, 2021
Greatly Transformed Sinovac Set To Reawaken On Wall Street?
The Bamboo Works
-
Dec 13, 2021, 8:13AM
Friday, December 03, 2021
Sinovac Says Beijing Settled Litigation Of Its Business License And Seals BZ NOTE: Shares Of Sinovac Have Not Traded In Over A Year
Benzinga Newsdesk
-
Dec 3, 2021, 11:21AM
Tuesday, November 09, 2021
Preliminary Results Show SINOVAC's COVID-19 Vaccine Demonstrates Good Safety Profile Among The Pediatric And Adolescent Population
Benzinga Newsdesk
-
Nov 9, 2021, 7:32AM
Friday, September 24, 2021
Sinovac's COVID-19 Vaccine Shows Efficacy, But Lags Rivals In Malaysian Study: Reuters
Vandana Singh
-
Sep 24, 2021, 9:16AM
Thursday, September 09, 2021
The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization
Shanthi Rexaline
-
Sep 9, 2021, 8:17AM
New Research On SINOVAC's COVID-19 Vaccine Shows Third Dose More Effective Against COVID-19, Including The Delta Variant
Benzinga Newsdesk
-
Sep 9, 2021, 6:07AM
Wednesday, September 08, 2021
SINOVAC Announces COVID-19 Vaccine Approved For Emergency Use In Chile For Children And Adolescents
Benzinga Newsdesk
-
Sep 8, 2021, 4:13PM
Thursday, August 26, 2021
Inovio To Start Global Late-Stage COVID-19 Vaccine Trial
Vandana Singh
-
Aug 26, 2021, 10:32AM
Tuesday, August 10, 2021
SINOVAC Announces Positive Data on Booster Shots of CoronaVac, Induces Strong Immune Response in Adult and Elderly Populations
Benzinga Newsdesk
-
Aug 10, 2021, 7:09AM
Tuesday, July 20, 2021
EMA Starts Rolling Review Of Glaxo - Sanofi COVID-19 Vaccine
Vandana Singh
-
Jul 20, 2021, 2:32PM
Monday, July 19, 2021
SINOVAC Receives Approval on Sabin Strain Based Inactivated Polio Vaccine To Support Global Polio Endgame Strategy
Benzinga Newsdesk
-
Jul 19, 2021, 7:08AM
Friday, July 16, 2021
Lancet Study Shows BioNTech COVID-19 Vaccine Generates 10X Higher Antibody Levels Compared to Sinovac Shot
Vandana Singh
-
Jul 16, 2021, 8:59AM
Wednesday, June 30, 2021
Sinovac Highlights Publication Of Phase I/II COVID-19 Study In The Lancet Infectious Diseases
Bill Haddad
-
Jun 30, 2021, 6:33AM
Wednesday, June 02, 2021
SINOVAC Biotech Ltd Announces The World Health Organization Authorized The Company's CoronaVac for Emergency Use
Benzinga Newsdesk
-
Jun 2, 2021, 7:32AM
Tuesday, June 01, 2021
WHO Approved Emergency Use Listing For COVID-19 Vaccine Made By Chinese Drug Maker Sinovac
Benzinga Newsdesk
-
Jun 1, 2021, 10:35AM
Tuesday, May 25, 2021
Sanofi, Walvax COVID-19 Vaccine Phase 3 Trials to Commence in Mexico: Reuters
Vandana Singh
-
May 25, 2021, 8:05AM
Monday, March 08, 2021
Sinovac COVID-19 Vaccine Prelim Data Shows Is Effective Against Brazilian P1 Variant; BZ NOTE: Sinovac Shares Do Not Currently Trade In US
Benzinga Newsdesk
-
Mar 8, 2021, 12:16PM
Philippines, Moderna Reach 13M Vaccine Doses Supply Pact
Vandana Singh
-
Mar 8, 2021, 7:09AM
Wednesday, February 17, 2021
Sinovac Vaccine Works On The UK And South African Strains
Benzinga Newsdesk
-
Feb 17, 2021, 5:12PM
Tuesday, February 16, 2021
Hong Kong Advisory Panel Approves China's Sinovac Covid-19 Vaccine for Emergency Use
Charles Gross
-
Feb 16, 2021, 6:38AM
Monday, February 08, 2021
Sinovac Says Receives Conditional Marketing Authorization In China For COVID-19 Vaccine
Benzinga Newsdesk
-
Feb 8, 2021, 7:30AM
Friday, February 05, 2021
Sinovac Announces The Results For Its Phase 3 Coronavirus Vaccine; Co. Says A Total Of 25K Patients Have Enrolled Across 4 Countries
Benzinga Newsdesk
-
Feb 5, 2021, 4:07PM
Wednesday, February 03, 2021
SinoVac Files For Conditional Market Authorization Of COVID-19 Vaccine In China; Says Preliminary Results Of Trials Demonstrated A Good Safety Profile For Vaccine
Benzinga Newsdesk
-
Feb 3, 2021, 9:55AM
Tuesday, February 02, 2021
UPDATE: Cassava Sciences Says Results Support Advancing Simufilam Into Phase 3 Clinical Program
Benzinga Newsdesk
-
Feb 2, 2021, 8:32AM
Wednesday, January 20, 2021
WHO Doc Shows Expectation For Approval Of COVID-19 Vaccines In China By Sinopharma, Sinovac In Mar. At Earliest
Benzinga Newsdesk
-
Jan 20, 2021, 10:29AM
Tuesday, January 12, 2021
'Sinovac's #COVID19 #vaccine is 100% effective in preventing severe and moderate infections, 78% effective in preventing mild cases, and has an overall efficacy of 50.4%, in Brazil's final-stage trials...'
Benzinga Newsdesk
-
Jan 12, 2021, 11:05AM
Monday, January 11, 2021
China's CoronaVac Vaccine Has A General Efficacy Of Less Than 60% In Brazilian Trial
Benzinga Newsdesk
-
Jan 11, 2021, 3:53PM
Thursday, January 07, 2021
Sauo Paulo's Butantan Institute Submitted Request For Emergency Use Of COVID-19 Vaccine Made By China's Sinovac
Benzinga Newsdesk
-
Jan 7, 2021, 10:07AM
Late Stage Trial Of Sinovac COVID-19 Vaccine In Brazil Shows Efficacy Of 78%
Benzinga Newsdesk
-
Jan 7, 2021, 9:20AM
Monday, December 28, 2020
Wuhan Launched Emergency Covid-19 Vaccinations for Key Groups According to Local CDC Official
Charles Gross
-
Dec 28, 2020, 5:06AM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch